# Efficacy and Safety Study of a IMSS Developed Phytopharmaceutical for the Treatment of Anxiety.

> **NCT03702803** · PHASE2 · UNKNOWN · sponsor: **Coordinación de Investigación en Salud, Mexico** · enrollment: 122 (estimated)

## Conditions studied

- Generalized Anxiety Disorder

## Interventions

- **DIETARY_SUPPLEMENT:** Galphimia glauca standardized extract
- **DRUG:** alprazolam 1mg

## Key facts

- **NCT ID:** NCT03702803
- **Lead sponsor:** Coordinación de Investigación en Salud, Mexico
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-03-16
- **Primary completion:** 2020-09-19
- **Final completion:** 2020-10-19
- **Target enrollment:** 122 (ESTIMATED)
- **Last updated:** 2020-07-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03702803

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03702803, "Efficacy and Safety Study of a IMSS Developed Phytopharmaceutical for the Treatment of Anxiety.". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03702803. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*